MKE-14751-65741
5 vaccinations
2 coded responses
54 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 441 / OH
- Registered
- 2021-04-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
BVS-23686-50373
Child or adolescent in my care · Male · 2021-11-12
VXY-33992-30673
Child or adolescent in my care · Male · 2022-07-13
Timeline
-
2021-03-31
Dose 1 — Pfizer-BioNTech
-
2021-04-24
Registered in v-safe
-
2021-04-24
Dose 2 — Pfizer-BioNTech
- 2021-04-24
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-05-03
- 2021-05-08
- 2021-05-15
-
2021-05-22
Survey response — day 28, dose 2MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Congestion, runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-29
- 2021-06-05
- 2021-07-24
-
2021-11-12
Dose 3 — Moderna
-
2021-11-12
Survey response — day 0, dose 3MedDRA: No adverse event — Feeling: Good · Site: PainFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2021-11-13
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-14
- 2021-11-15
- 2021-11-16
- 2021-11-18
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2022-02-13
- 2022-05-13
-
2022-07-13
Dose 4 — Moderna
- 2022-07-13
-
2022-07-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
-
2022-07-15
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
- 2022-07-16
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-20
- 2022-07-27
- 2022-08-03
- 2022-08-10
- 2022-08-17
- 2022-08-24
- 2022-10-12
-
2022-10-20
Dose 5 — Moderna
- 2022-10-22
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-10-27
- 2022-11-03
- 2022-11-10
- 2022-11-17
- 2022-11-24
- 2022-12-01
- 2023-01-19
- 2023-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech | |
| 3 | 2021-11-12 | Moderna | No |
| 4 | 2022-07-13 | Moderna | No |
| 5 | 2022-10-20 | Moderna | No |
Free text
Release 8 — day 28, dose 2
Symptoms: Congestion, runny nose
Release 10 — day 0, dose 3
Systemic reaction (other): No
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release